Neos Therapeutics (NEOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 4,382 | 1,583 | 1,485 | 2,583 | 1,659 |
| Cost of Goods | 4,317 | 2,318 | 2,343 | 2,756 | 2,003 |
| Gross Profit | 65 | -735 | -858 | -173 | -344 |
| Operating Expenses | 16,604 | 23,316 | 23,489 | 12,448 | 8,074 |
| Operating Income | -16,222 | -23,733 | -24,004 | -11,865 | -8,415 |
| Interest Expense | 2,191 | 2,130 | 1,604 | 1,012 | 1,036 |
| Other Income | 621 | 57 | -931 | 263 | 347 |
| Pre-tax Income | -17,792 | -25,806 | -26,539 | -12,614 | -9,104 |
| Net Income Continuous | -17,792 | -25,806 | -26,539 | -12,614 | -9,104 |
| Net Income | $-17,792 | $-25,806 | $-26,539 | $-12,614 | $-9,104 |
| EPS Basic Total Ops | -1.11 | -1.61 | -1.65 | -0.79 | 12.71 |
| EPS Basic Continuous Ops | -1.11 | -1.61 | -1.65 | -0.79 | 10.59 |
| EPS Diluted Total Ops | -1.11 | -1.61 | -1.65 | -0.79 | 12.71 |
| EPS Diluted Continuous Ops | -1.11 | -1.61 | -1.65 | -0.79 | 10.59 |
| EBITDA(a) | $-15,588 | $-22,882 | $-22,982 | $-10,862 | $-7,438 |